People / Staff

Arielle Kane

Arielle Kane is the director of health care at PPI. Her research focuses on what comes next for health policy in order to expand access, reduce costs and improve quality. Specifically, she focusses on how innovation in health care can help meet the goals of the triple aim. Prior to joining PPI, she worked at the Deloitte Center for Health Solutions where she researched provider issues, including conducting a survey of health system CEOs on the future of health care; policy issues, including analysis of the recent tax overhaul; and managed a weekly newsletter which provided updates and analysis on health policy and industry news. Arielle also worked in Oregon politics prior to moving to Washington, DC. Arielle received her Master of Public Policy from Georgetown University. She lives in Washington, DC with her bulldog, Hank.



By / 4.16.2019

Too many Americans lack access to dental care, especially in underserved areas. Forty-four percent of people below the federal poverty level have untreated dental decay compared to just 9.5 percent of those above 400 percent of the federal poverty level. The consequences of untreated decay and periodontal disease – slowly destructive gum infections – include […]


Last week PPI returned to Des Moines for a second “Conversation with Iowans,” this time about progressive alternatives to nationalized health care. The ideas forum featured former Colorado Gov. and presidential aspirant John Hickenlooper, Theresa Greenfield, a Des Moines business owner, PPI President Will Marshall and yours truly. A strong turnout and often impassioned debate […]


By / 4.15.2019

When it comes to health care, Americans could not face a clearer choice. Progressives believe all Americans should have access to affordable, high-quality health coverage. Republicans want to kill the Affordable Care Act – thereby depriving an additional 17 million Americans of insurance – and have no credible plan to replace it. Too often, however, […]


By / 3.26.2019

On the campaign trail, Donald Trump promised no cuts to Medicaid, that he would protect those with preexisting conditions, and that everyone would have insurance under his new health care plan. He has broken every one of those promises over the last two years. What’s more, the White House campaign to sabotage the Affordable Care […]


By / 3.19.2019

A bill working its way through the Minnesota state legislature would prohibit drugmakers from “price gouging” for essential prescription drugs. The law seeks to end some pretty egregious behavior by bad actors in the biopharmaceutical industry. Like any industry, the drug industry has its share of bad actors. The loathsome “pharma bro” Martin Shkreli is […]


By / 3.1.2019

In searching for ways to satisfy public demand for lower drug prices, President Trump has found rare common ground with Democrats. The White House recently released a plan to reform the way pharmacy benefit managers (PBMs) negotiate prices with drugmakers on behalf of health insurance companies. Specifically, the proposal takes aim at special discounts or […]


By / 2.14.2019

America’s massive health care industry faces three major challenges: how to cover everyone, reduce costs, and increase productivity. Telehealth – the use of technology to help treat patients remotely – may help address all three. Telehealth reduces the need for expensive real estate and enables providers to better leverage their current medical personnel to provide […]